Anti-Human CD30 Recombinant Antibody(Brentuximab)
-
产品编号
YR1614
-
别名
科研级 Brentuximab ( 本妥昔单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Brentuximab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Brentuximab ( 本妥昔单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Brentuximab |
| Catalog Number | YR1614 |
| Molecular Name | Brentuximab |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | Human IgG1 |
| Formulation | PBS, pH7.5 |
| Background | Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL. |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Molecular Weight | 150 kDa |
| Target | CD30[Homo sapiens] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
